FDA approves BioSante/Teva’s testosterone gel (Reuters)

Reuters – U.S. drug regulators approved a new testosterone gel from BioSante Pharmaceutical Inc and Teva Pharmaceuticals, a Food and Drug Administration spokeswoman said.